Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

Autor: Fallowfield, Lesley, Jenkins, Valerie, Kilkerr, Justine, Langridge, Carolyn, Monson, Kathryn, Jakobsen, Erik Hugger, Nielsen, Mette Holck, Linnet, Soeren, Knoop, Ann, Pivot, Xavier, Bonnefoi, Herve, Mousseau, Mireille, Zelek, Laurent, Bourgeois, Hugues, Lefeuvre, Claudia Plesse, Bachelot, Thomas, Petit, Thierry, Brain, Etienne, Levy, Christelle, Gligorov, Joseph, Augustin, Doris, Graf, Heiko, Heinrich, Georg, Kroening, Hendrik, Kuemmel, Sherko, Müller, Volkmar, Overkamp, Friedrich, Park-Simon, Tjoung-Won, Schmidt, Marcus, Perlova-Griff, Lidia, Wolf, Christopher, Colleoni, Marco, Ballestrero, Alberto, Bernardo, Antonio, Ribecco, Angela Stefania, Gianni, Luca, Curigliano, Giuseppe, Brewczynska, Elżbieta, Jassem, Jacek, Shirinkin, Vadim, Manikhas, Alexey, Dvornichenko, Victoria, Lichinitser, Mikhail, Semiglazov, Vladimir, Mukhametshina, Guzel, Bulavina, Irina, Arranz, Enrique Espinosa, Ocon, Francisco Carabantes, Vivanco, Guillermo López, Bofill, Javier Salvador, Quintela, Ignacio Porras, Muñoz, Alfonso Sanchez, Pérez, Yolanda Fernández, Espinosa, Javier Cassinello, Alvarez, José Valero, del Prado, Rodrigo Lastra, De Merino, LuisLa Cruz, García, José Manuel Pérez, Frances, Santos Enrech, Edlund, Per, Norberg, Bengt, Wennstig, Anna-Karin, Lind, Pehr, Hauser, Nik, Tausch, Christoph, Camci, Celalettin, Arpaci, Fikret, Abali, Huseyin, Uslu, Ruchan, Tahir, Saad, Wheatley, Duncan, Chan, Stephen, Barrett-Lee, Peter, McAdam, Karen, Simcock, Richard, Burcombe, Russell, El-Maraghi, Robert, Califaretti, Nadia, Spadafora, Silvana, Sehdev, Sandeep, Sami, Amer, Verma, Sunil, Pivot, X. ^*, Gligorov, J., Müller, V., Curigliano, G., Knoop, A., Verma, S., Jenkins, V., Scotto, N., Osborne, S., Fallowfield, L.

Publikováno v: In Annals of Oncology October 2014 25(10):1979-1987

Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer

Autor: ÖZKAN, Metin, Dikilitas, Mustafa, Altinbas, Mustafa, Sevinc, Alper, Kalender, Mehmet Emin, Camci, Celalettin

Objectives: The present study was designed to investigate the efficacy of irinotecan monotherapy as a second-line treatment for small cell lung cancers (SCLCs). Methods: Irinotecan monotherapy was administered to 46 SCLC patients who were previously

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______9447::bd9def69d47b47ba1e49d6e87ab652d1
https://avesis.erciyes.edu.tr/publication/details/60b7e418-13c1-42b4-98c3-1b4ab9010c15/oai

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment approaches for metastatic breast cancer in Turkey

Autor: GÜMÜŞ, MAHMUT, SAVAŞ, HANDE, ÖBER, AHMET, ŞENEL BEŞE, NURAN, DEMİRKAN, HATİCE MİRAÇ BİNNAZ, KÖKSAL, GÜLİSTAN, UYGUN, KAZIM, ARAN, METİN, KAYAR, RAGIP, ÜNSAL, MUSTAFA, DÖNMEZ, BİNNUR, ALAN, ÖMÜR, ZENGEL, BAHA, YÜCEL, İDRİS, ÜSKENT, NECDET, TECİMER, ÇOŞKUN, TURHAL, SERDAR, ÖNCEL, TAYANÇ, İRGİL, CEYHUN, ATASOY, GÜVEN, AKSAZ, EROL, MAYADAĞLI, ALPASLAN, KIZILKAYA, ORHAN, DİŞEL, UMUT, TEKİN, SALİM BAŞOL, ŞAN, MERİH, İÇLİ, FİKRİ, BÜYÜKÇELİK, ABDULLAH, ALKIŞ, NECATİ, ZENGİN, NURULLAH, ÖZTÜRK, BEKİR, ÖZET, AHMET, KÖMÜRCÜ, ŞEREF, ARPACI, FİKRET, SAMUR, MUSTAFA, ÖZDOĞAN, MUSTAFA, MEYDAN, NEZİH, BARUTCA, SABRİ, EKEN, AYNUR, YILDIRIM, İBRAHİM, TANLAK, GÜNAY, GEMİCİ, CENGİZ, SALEPÇİ, TAFLAN, SERDENGEÇTİ, SÜHEYLA, ERKİŞİ, MELEK, YAVUZ, SİNAN, TAÇYILDIZ, İBRAHİM HALİL, ALAKAVUKLAR, MEHMET, ALANYALI, HİLMİ FEYZİ, GÖKER, ERDEM, KARABULUT, BÜLENT, SEZGİN, CANFEZA, ALTINBAŞ, MUSTAFA, CAMCI, CELALETTİN, TÜRK, HACI MEHMET, GÜLER, NİLÜFER, KANDEMİR, GÖKHAN, ALİUSTAOĞLU, MEHMET, TOPUZ, ERKAN, AYDINER, ADNAN, YAYLACI, MUSTAFA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2605::68a3d62343a1b860a5d0f3c50af583f7
https://avesis.deu.edu.tr/publication/details/7caee905-36eb-4f8e-8ba0-2ac1d69f18c4/oai

Cardiotoxic drugs in breast cancer

Autor: Sevinc, Alper, Buyukberber, Suleyman, Camci, Celalettin

The African-American race was examined as a risk factor for cardiotoxicity from doxorubicin-based therapy for cancer.Retrospective survey of the Howard University Hospital cancer registry during 1997-2001 identified 100 evaluable patients out of 120

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::df673d765a9f36f6b119c0dba7e6fb1e
https://europepmc.org/articles/PMC2640667/